Pubblicazioni

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response

2016 - LEUKEMIA & LYMPHOMA

Latagliata, R.; Romano, A.; Mancini, M.; Breccia, M.; Carmosino, I.; Vozella, F.; Montagna, C.; Volpicelli, P.; De Angelis, F.; Petrucci, L.; Serrao, A.; Molica, M.; Salaroli, A.; Diverio, D.; Alimena, G.

Donor lymphocyte infusions for chronic myeloid leukemia relapsing after allogeneic stem cell transplantation. may we predict graft-versus-leukemia without graft-versus-host disease?

2015 - BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Radujkovic, Aleksandar; Guglielmi, Cesare; Bergantini, Stefania; Iacobelli, Simona; van Biezen, Anja; Milojkovic, Dragana; Gratwohl, Alois; Schattenberg, Antonius V. M. B.; Verdonck, Leo F.; Niederwieser, Dietger W.; de Witte, Theo; KrÃ¶ger, Nicolaus; Olavarria, Eduardo